Register entry
- Registered sites
- 0
- Active NDC listings
- 5
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
55 active NDC listings: 5 human otc drug. By marketing category: OTC MONOGRAPH DRUG 4, UNAPPROVED HOMEOPATHIC 1.
| Dosage form | NDCs |
|---|---|
| cream | 4 |
| lotion/shampoo | 1 |
| Route | NDCs |
|---|---|
| topical | 5 |
| Labeller name on the listing | NDCs |
|---|---|
| regeneren plus ltd | 5 |
Catalogue
Marketed products
5| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Recuren Plus Antifungal Cream | Miconazole Nitrate 2% | cream, topical | 87014-001OTC MONOGRAPH DRUG |
| Recuren Plus Arnica Bruise Cream | Arnica Montana 7% | cream, topical | 87014-002UNAPPROVED HOMEOPATHIC |
| Recuren Plus Balanced Scalp | Salicylic Acid | lotion/shampoo, topical | 87014-006OTC MONOGRAPH DRUG |
| Recuren Plus Face Cream | Salicylic Acid 0.5%, Zinc Pyrithione 0.25% | cream, topical | 87014-005OTC MONOGRAPH DRUG |
| Recuren Plus Jock Itch Cream | Miconazole Nitrate 2% | cream, topical | 87014-004OTC MONOGRAPH DRUG |
Compare
Other companies listing miconazole nitrate 2%
- Derma Care Research Labs, LLC1 site · 69 NDC
- Twin Med LLC0 sites · 58 NDC
- Guangzhou Huixue Biotechnology Co., Ltd.0 sites · 46 NDC
- Beautivity LLC0 sites · 36 NDC
- Guangxi Keyun E-commerce Co., Ltd.0 sites · 20 NDC
- Gentell LLC0 sites · 17 NDC
- SpineStatus LLC0 sites · 2 NDC
Enquiry
Common questions
- Is REGENEREN PLUS LTD FDA approved?
- REGENEREN PLUS LTD holds no registered establishment of its own; 5 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does REGENEREN PLUS LTD make?
- 5 products are listed under REGENEREN PLUS LTD in the openFDA NDC Directory, most often as cream; lotion/shampoo. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.